• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ADVANTAGE SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ADVANTAGE SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR Back to Search Results
Model Number M0068502000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Incontinence (1928); Urinary Retention (2119); Injury (2348); Obstruction/Occlusion (2422); No Code Available (3191)
Event Date 01/31/2008
Event Type  Injury  
Manufacturer Narrative
Date of event: date of event was approximated to (b)(6) 2008 (implant date) as no event date was reported.This complaint was reported by the patient's lawyer.The device was implanted at (b)(6) by dr.(b)(6).(b)(4).The complainant indicated that the device is not available for return; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that an advantage system was implanted into the patient on (b)(6) 2008.As reported by the patient's attorney, the patient underwent a revision surgery on (b)(6) 2013 due to stress incontinence and failed sling.Synthetic sling identified and freed segment over the urethra was removed and was sent for histopathology.On (b)(6) 2013, the patient underwent another revision surgery due to obstructive voiding.On (b)(6) 2104, the patient underwent a revision surgery due to urge incontinence.On (b)(6) 2017, the patient underwent cystoscopy with biopsy of bladder procedure due to obstructive lower urinary tract symptoms and incomplete bladder emptying.Upon vaginal examination, sling erosion was noted on the right anterior vaginal wall with some sling eroding out.Part of the sling that eroded was excised.On (b)(6) 2017, she had another revision surgery due to sling erosion and voiding dysfunction.On (b)(6) 2017, patient underwent cystoscopy with urethroscopy procedure due to an obstructive sub-urethral sling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANTAGE SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
FREUDENBERG MEDICAL MIS INC
2301 centennial boulevard
jeffersonville IN 47130
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key11135448
MDR Text Key225753186
Report Number3005099803-2020-06596
Device Sequence Number1
Product Code OTN
UDI-Device Identifier08714729470274
UDI-Public08714729470274
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K020110
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Other
Type of Report Initial
Report Date 01/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2010
Device Model NumberM0068502000
Device Catalogue Number850-200
Device Lot Number0ML7051001
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/11/2020
Initial Date FDA Received01/07/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/07/2007
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age44 YR
-
-